A phase I study of flavopiridol in combination with gemcitabine and irinotecan in patients with metastatic cancer
Phase of Trial: Phase I
Latest Information Update: 24 Jan 2013
At a glance
- Drugs Alvocidib (Primary) ; Gemcitabine; Irinotecan
- Indications Solid tumours
- Focus Adverse reactions
- 17 Jan 2008 Status changed from in progress to completed.
- 20 Jun 2007 Status changed from recruiting to in progress.
- 19 Aug 2005 New trial record.